Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA
Research Article
[키워드] 350 patient
Altered mental status
bacterial pathogen
C‐reactive protein
caused
Characteristics
Chest
Clinical characteristics
common
Comorbidities
complications
coronavirus
Coronavirus disease 2019
cough
Course
COVID‐19
D‐dimer
described
diagnosed
died
early recovery
elevated
Epidemiology
erythrocyte sedimentation rate
facilitate
fatigue
Fever
FIVE
Gastrointestinal symptom
hospital
Hospitalization
humans
ICU
immune responses
include
Infection
interleukin
knowledge
laboratory parameter
lactate dehydrogenase
lymphopenia
morbidity
Mortality
myalgia
Mycoplasma pneumoniae
one patient
outcome
pandemic
Pandemics
Pathogenesis
Patient
patients
Pneumonia
pneumoniae
reported
Respiratory illness
Respiratory pathogens
respiratory symptoms
respiratory tract
SARS Coronavirus
SARS‐CoV‐2
Serum ferritin
Shortness of breath
Symptom
the patient
treated
Treatment
USA
virus classification
World Health Organization
[DOI] 10.1002/jmv.26026 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1002/jmv.26026 PMC 바로가기 [Article Type] Research Article